Sanofi and GSK recently announced they will delay a program testing an adjuvanted COVID-19 vaccine after results from a Phase 1/2 study showed a low immune response in older adults.
The...
Moderna recently announced that the Canadian Government will now acquire an additional 20 million doses of its mRNA COVID-19 vaccine, bringing the total to 40 million doses.
The updated...
Moderna recently announced that the first adolescent patients have been dosed in the Phase 2/3 study of its mRNA-based COVID-19 vaccine, mRNA-1273.
The randomized, controlled Phase 2/3 study will...
Roche recently announced a partnership with Moderna to utilize the Elecsys COVID-19 antibody test in Moderna’s mRNA-1273 vaccine research clinical trials.
The partnership will allow for easier...
Pfizer recently announced that 83 percent of patients in the ongoing Phase 1 study of its investigational multiple myeloma antibody drug achieved clinical response at the highest dose level.
The...
Ovid Therapeutics recently announced that the Phase 3 clinical trial of its rare disease drug for the treatment of Angelman syndrome did not meet primary endpoints.
Specifically, OV101, or...
Eli Lilly and Company and UnitedHealth Group recently announced a partnership to conduct a pragmatic study of the COVID-19 antibody LY-CoV555 in high-risk individuals infected with the...
GSK recently announced that it will begin a Phase 3 study investigating the safety and efficacy of its Respiratory Syncytial Virus (RSV) vaccine candidate for maternal immunization.
The...
Moderna recently announced that a second primary analysis of its COVID-19 vaccine candidate, mRNA-1273, found a 94.1 percent vaccine efficiency against the coronavirus.
The Phase 3 study, COVE,...
Siemens Healthineers recently announced the launch of its COVID-19 antibody test, which has previously proven to measure neutralizing antibodies and has achieved CE Mark.
Notably, the SARS-CoV-2...
An American Heart Association study recently found that patients taking cholesterol-lowering statin medication and patients taking a placebo reported the same side effects.
Specifically,...
Sanofi and Translate Bio recently announced positive preclinical results for their mRNA-based COVID-19 vaccine candidate in mice.
Specifically, the candidate called MRT5500 induced "potent"...
Regeneron Pharmaceuticals recently announced that its COVID-19 antibody cocktail reduced viral load and alleviated symptoms in non-hospitalized coronavirus patients in a Phase 1/2/3 clinical...
Abbott recently announced the first patient has been enrolled in a study to investigate the efficacy of the company’s BurstDR spinal cord stimulation (SCS) in individuals with chronic low back...
ViiV Healthcare recently announced the start of a study that will evaluate the best approaches to implementing an investigational HIV treatment that needs to be injected into patients twice a...
Eli Lilly and Amgen recently announced a global manufacturing collaboration to increase the supply of Lilly’s potential COVID-19 antibody therapies.
If one or more of Lilly’s...
Johnson & Johnson recently announced early positive results from the ongoing Phase 1/2a clinical trial of its COVID-19 vaccine candidate.
The results published in medRxiv, a preprint server for...
Bristol Myers Squibb recently announced that its immunotherapy, Opdivo (nivolumab), improved disease-free survival versus a placebo for patients with high-risk, muscle-invasive bladder cancer in a...
Johnson & Johnson recently announced the launch of a large-scale, multi-country Phase 3 clinical trial for its COVID-19 vaccine candidate, JNJ,78436735.
The ENSEMBLE trial will enroll nearly...
Sixty-four higher-income economies recently joined the COVAX Facility, a global COVID-19 response effort that ensures governments and manufacturers have access to COVID-19 vaccines, according to an...
